Noradrenalin Nardia 0,032 mg/ml, soluzione per infusione

7680703260029 CH-70326 soluzione

Associated product:

NORADRENALIN Nardia 8 mg/250ml sol perf

No image available

Article details

Package size
10 x 250 ml
Selling units
10
Measure
Beutel
Galenic form
soluzione
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/08/2026
Summary of Product Characteristics
Français
27/08/2026
Summary of Product Characteristics
Italien
27/08/2026

Detailed composition

Substance Quantity Type Category
noradrenalinum
0.032 MG Substance Wirkstoff (Principe actif)
noradrenalini tartras
- Substance WIZUS
natrii chloridum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.5 MG Substance HBESI

Authorization holder

Nardia Pharmaceuticals SA

6855 Stabio

Authorization information

Swissmedic authorization number
70326
Drug name
Noradrenalin Nardia, soluzione per infusione
Galenic form
LSINF
ATC Code
C01CA03
Authorization status
Z
Dispensing category
B
First authorization
06/07/2026
Authorization expiration date
05/07/2031
IT Number
02.05.2.
Domain
Human medicine

Package details

Description (FR)
NORADRENALIN Nardia 8 mg/250ml sol perf
Description (DE)
NORADRENALIN Nardia 8 mg/250ml Inf Lös
Market launch
01/12/2026
Narcotic (BTM)
No

Other package sizes (2)

NORADRENALIN Nardia 4 mg/250ml sol perf
10 x 250 ml BEU
GTIN: 7680703260012
View
NORADRENALIN Nardia 16 mg/250ml sol perf
10 x 250 ml BEU
GTIN: 7680703260036
View
Buy us a coffee Explore the data